Stigma of Mental Illness in China: Extending the SGC-MHS

描述（由研究者提供）：根据美国卫生局局长和世界卫生组织（WHO）的说法，精神疾病（MI）的耻辱是识别，治疗和康复的最关键障碍之一。在Fogarty国际中心的一项特别计划下，并在国家心理健康研究所和行为与社会科学研究办公室的额外支持下，开展了全球背景下的污名-心理健康研究（SGC-MHS），以了解各国对MI的理解和污名化程度。尽管纳入了广泛的国家，但中国在SGC-MHS数据集中明显缺席。该申请旨在通过将对中国的实质性专业知识及其独特的采样挑战与SGC-MHS研究人员的经验相结合来填补这一空白。本申请建议：1）使用SGC-MH研究工具的定制版本，估计中国污名的性质、水平和个体水平的相关性; 2）使用SGC-MHS中国模块收集的调查数据，检验关于障碍，特别是污名，对医疗和精神卫生服务认可的影响的假设; 3）将SGC-MHS中国模块的数据整合到更大的16国研究中，以检查污名的原因和相关因素。为此，将使用定制版SGCMHS工具，通过面对面访谈从中国人群的全国代表性样本（N= 5，250）中收集数据。将中国加入SGC-MHS将有助于加深对污名根源的理解，提高对全球污名负担的估计，并为中国和其他地区减少污名提供重要的科学基础。 公共卫生相关性：中国人口占世界人口的五分之一，在全球疾病负担中占相当大的份额，包括精神疾病。现有的研究表明，污名塑造了个体（例如，服务使用率低、偏见、歧视）和系统问题（例如，治疗资源不足）。研究中国污名化态度、信念和行为倾向的根源和潜在后果，将显著改善科学理解、干预措施的制定以及SGC-MHS现有跨国合作提供的数据的政策含义。

DESCRIPTION (provided by investigator): According to the U.S. Surgeon General and the World Health Organization (WHO), the stigma attached to mental illness (MI) stands as one of the most critical barriers to recognition, treatment and recovery. Under a special program of the Fogarty International Center and with additional support from the National Institute of Mental Health and the Office of Behavioral and Social Science Research, the Stigma in Global Context - Mental Health Study (SGC-MHS) was mounted to understand the extent to which MI is understood and stigmatized across countries. Despite the inclusion of a wide range of countries, China stands as a notable absence in the SGC-MHS data set. This application is designed to fill that gap by combining substantive expertise on China and its unique sampling challenges with the experience of SGC-MHS researchers. This application proposes to : 1) Estimate the nature, level and individual level correlates of stigma in China using a tailored version of the SGC-MH Study instrument; 2) Use the survey data collected by the Chinese module of the SGC-MHS to test hypotheses concerning the influences of barriers, particularly stigma, to the endorsement of medical and mental health services; 3) Integrate the data from the Chinese module of the SGC-MHS into the larger 16 nation study to examine the causes and correlates of stigma. Towards these ends, data will be collected from a nationally representative sample of the Chinese population (N= 5,250) in face-to-face interviews using a tailored version of the SGCMHS instrument. Adding China to the SGC-MHS will improve understanding of the underlying roots of stigma, sharpen estimates of the global burden of stigma, and provide a critical, scientific base for stigma reduction in China and elsewhere. PUBLIC HEALTH RELEVANCE: With one-fifth of the world's population, China accounts for a sizable share of the global burden of disease, including mental illness. Existing research indicates that stigma shapes both individual (e.g., low service use, prejudice, discrimination) and system problems (e.g., inadequate treatment resources). Examining both the roots and the potential consequences of stigmatizing attitudes, beliefs, and behavioral predispositions in China would significantly improve scientific understanding, the development of interventions and the policy implications of data provided by the existing cross-national collaboration in the SGC-MHS.